Key summary of German national treatment guidance for hospitalized COVID-19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021).

Malin JJ, Spinner CD, Janssens U, Welte T, Weber-Carstens S, Schälte G, Gastmeier P, Langer F, Wepler M, Westhoff M, Pfeifer M, Rabe KF, Hoffmann F, Böttiger BW, Weinmann-Menke J, Kersten A, Berlit P, Krawczyk M, Nehls W, Fichtner F, Laudi S, Stegemann M, Skoetz N, Nothacker M, Marx G, Karagiannidis C, Kluge S

Open source

DOI: 10.1007/s15010-021-01645-2
Published: 2022 Feb
Container: Infection
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s15010-021-01645-2,
  title = {Key summary of German national treatment guidance for hospitalized COVID-19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021).},
  author = {Malin JJ and Spinner CD and Janssens U and Welte T and Weber-Carstens S and Schälte G and Gastmeier P and Langer F and Wepler M and Westhoff M and Pfeifer M and Rabe KF and Hoffmann F and Böttiger BW and Weinmann-Menke J and Kersten A and Berlit P and Krawczyk M and Nehls W and Fichtner F and Laudi S and Stegemann M and Skoetz N and Nothacker M and Marx G and Karagiannidis C and Kluge S},
  year = {2022},
  journal = {Infection},
  doi = {10.1007/s15010-021-01645-2},
  url = {https://doi.org/10.1007/s15010-021-01645-2}
}

RIS

TY  - JOUR
TI  - Key summary of German national treatment guidance for hospitalized COVID-19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021).
AU  - Malin JJ
AU  - Spinner CD
AU  - Janssens U
AU  - Welte T
AU  - Weber-Carstens S
AU  - Schälte G
AU  - Gastmeier P
AU  - Langer F
AU  - Wepler M
AU  - Westhoff M
AU  - Pfeifer M
AU  - Rabe KF
AU  - Hoffmann F
AU  - Böttiger BW
AU  - Weinmann-Menke J
AU  - Kersten A
AU  - Berlit P
AU  - Krawczyk M
AU  - Nehls W
AU  - Fichtner F
AU  - Laudi S
AU  - Stegemann M
AU  - Skoetz N
AU  - Nothacker M
AU  - Marx G
AU  - Karagiannidis C
AU  - Kluge S
PY  - 2022
JO  - Infection
DO  - 10.1007/s15010-021-01645-2
UR  - https://doi.org/10.1007/s15010-021-01645-2
ER  -

APA

JJ, M., CD, S., U, J., T, W., S, W., G, S., P, G., F, L., M, W., M, W., M, P., KF, R., F, H., BW, B., J, W., A, K., P, B., M, K., W, N., F, F., S, L., M, S., N, S., M, N., G, M., C, K., & S, K. (2022). Key summary of German national treatment guidance for hospitalized COVID-19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021).. Infection. https://doi.org/10.1007/s15010-021-01645-2

Source records

pubmed · retrieved 2026-09-26T04:13:07.373Z
europe-pmc · retrieved 2026-09-26T04:13:07.280Z